- Home
- HUMA vs JRS Comparison
HUMA vs JRS Comparison
Compare HUMA & JRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HUMA
- JRS
- Stock Information
- Founded
- HUMA 2004
- JRS 2001
- Country
- HUMA United States
- JRS United States
- Employees
- HUMA N/A
- JRS N/A
- Industry
- HUMA Biotechnology: Pharmaceutical Preparations
- JRS Finance/Investors Services
- Sector
- HUMA Health Care
- JRS Finance
- Exchange
- HUMA Nasdaq
- JRS Nasdaq
- Market Cap
- HUMA 250.2M
- JRS 241.3M
- IPO Year
- HUMA N/A
- JRS N/A
- Fundamental
- Price
- HUMA $1.70
- JRS $8.12
- Analyst Decision
- HUMA Strong Buy
- JRS
- Analyst Count
- HUMA 8
- JRS 0
- Target Price
- HUMA $10.88
- JRS N/A
- AVG Volume (30 Days)
- HUMA 2.9M
- JRS 86.6K
- Earning Date
- HUMA 11-07-2025
- JRS 01-01-0001
- Dividend Yield
- HUMA N/A
- JRS 8.87%
- EPS Growth
- HUMA N/A
- JRS N/A
- EPS
- HUMA N/A
- JRS N/A
- Revenue
- HUMA $818,000.00
- JRS N/A
- Revenue This Year
- HUMA N/A
- JRS N/A
- Revenue Next Year
- HUMA $1,619.38
- JRS N/A
- P/E Ratio
- HUMA N/A
- JRS N/A
- Revenue Growth
- HUMA N/A
- JRS N/A
- 52 Week Low
- HUMA $1.15
- JRS $5.95
- 52 Week High
- HUMA $6.77
- JRS $8.00
- Technical
- Relative Strength Index (RSI)
- HUMA 52.69
- JRS 54.55
- Support Level
- HUMA $1.45
- JRS $8.08
- Resistance Level
- HUMA $1.53
- JRS $8.23
- Average True Range (ATR)
- HUMA 0.10
- JRS 0.08
- MACD
- HUMA 0.05
- JRS -0.01
- Stochastic Oscillator
- HUMA 65.31
- JRS 38.10
About HUMA Humacyte Inc.
Humacyte Inc is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions. Company's pipeline includes Vascular Trauma, PAD, Dailysis, Acellular Tissue Engineered Vessels, Organ Systems, Advanced Tissue Constructs.
About JRS Nuveen Real Estate Income Fund of Beneficial Interest
Nuveen Real Estate Income Fund is a diversified closed-end investment company. The Fund invests in income-producing common stocks, preferred stocks, convertible preferred stocks, and debt securities issued by real estate companies.